"overall cancer" trang 11 - tải miễn phí từ tailieunhanh
Adjuvant chemotherapy for stage III colon cancer: Relative dose intensity and survival among veterans

Adjuvant chemotherapy for stage III colon cancer: Relative dose intensity and survival among veterans
13    52    1
The prognostic significance of age in operated and non-operated colorectal cancer

The prognostic significance of age in operated and non-operated colorectal cancer
11    35    1
Metaplastic breast cancer: A comparison between the most common histologies with poor immunohistochemistry factors

Metaplastic breast cancer: A comparison between the most common histologies with poor immunohistochemistry factors
9    53    1
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
8    23    1
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use programme in France

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use programme in France
9    26    1
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
10    62    1
Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer
11    29    1
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
14    31    1
Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer

Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer
12    49    1
A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI
9    36    1
Cost-effectiveness of family history-based colorectal cancer screening in Australia

Cost-effectiveness of family history-based colorectal cancer screening in Australia
10    41    1
The survival and the long-term trends of patients with gastric cancer in Shanghai, China

The survival and the long-term trends of patients with gastric cancer in Shanghai, China
12    67    1
Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: Prognostic significance

Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: Prognostic significance
10    51    1
A retrospective analysis of survival and prognostic factors of male breast cancer from a single center

A retrospective analysis of survival and prognostic factors of male breast cancer from a single center
5    38    1
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: Prolongation of prostate-specific antigen doubling time

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: Prolongation of prostate-specific antigen doubling time
10    51    1
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
5    41    1
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: A safe and effective approach

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: A safe and effective approach
8    30    1
PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104

PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104
10    45    1
Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A systematic review

Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A systematic review
9    54    1
Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients

Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients
10    53    1